Target intelligence / Profile preview

RNA, U6 small nuclear 1314, pseudogene (RNU6-1314P)

Target
RNU6-1314P
Molecular classification
Pseudogene, Non-coding RNA-derived pseudogene
01

Overview

RNA, U6 small nuclear 1314, pseudogene (RNU6-1314P) is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) family[1][3][4]. Unlike functional U6 snRNA genes, which participate in the spliceosome to catalyze pre-mRNA splicing[5][7], this locus is a non-functional genomic copy that arose through retrotransposition and does not encode a functional molecule or protein[1][3][6]. Pseudogenes like RNU6-1314P are common in the human genome, serving as evolutionary remnants without known regulatory or coding roles[1][6]. There are no documented disease associations, drug interactions, or utility as a biomarker for this locus, and it is not considered a therapeutic target[1][3][4]. This entry is included in genetic databases for completeness but lacks clinical or functional significance. Summary of potential issues: - This is a pseudogene, not a functional gene, protein, receptor, or RNA molecule[1][3]. - There is no evidence it acts as a therapeutic target or is relevant for drug development. - It has no documented biological function, disease role, or biomarker status. If you are seeking information on the functional U6 small nuclear RNA, refer to canonical "U6 snRNA" or "RNA, U6 small nuclear" (not the pseudogene)[5][7].

Other names
RNU6-1314P
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, it does not have a biological function)
04

Disease associations

None documented (no established role in disease as a pseudogene)
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, U6 small nuclear 1314, pseudogene (RNU6-1314P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1314, pseudogene (RNU6-1314P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call